Lung expression of interleukin-13 (IL-13) and interferon gamma (IFNg) in emphysema in human Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Interleukin -18 (IL-18) and tumor necrosis factor (TNF) in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Interleukin 4 (IL-4) mRNA expression in peripheral blood CD4+ T cells and adhesion molecule profile in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 272s Year: 2001
Endotoxin-induced release of the Th17-associated cytokine interleukin (IL)-26 in human neutrophils Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Interleukin (IL-13) modulates allergen-induced airway hyperresponsiveness by a pathway independent of IL-5 or eotaxin in mice Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003
The ratio of interleukine-4( IL-4) and interferon-γ( IFN- γ) in expired air condensate(EAC) of atopic children Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Combined effect of anti-IgE (omalizumab) and specific immunotherapy (SIT) on in vitro release of leukotrienes (LT) and the cytokines IL-4 and interferon-gamma (IFN) Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL) 1-beta in small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001
HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells Source: Eur Respir J 2002; 20: 1174-1178 Year: 2002
Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002
Interleukin-4 and interferon-gamma production by allergen and PPD stimulated T-cells in the presence of IL-12 and IL-18 Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001
Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma Source: Eur Respir J 2003; 22: 310-316 Year: 2003
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Decreased T-bet expression and changes in levels of chemokines (IP-10, MIG, RANTES, MCP-1 and IL-8) in peripheral blood of adults with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 593s Year: 2006
Evaluation in bronchoalveolar lavage fluid (BALF) of cytokines TNF-alpha, IL-6 and IL-8 in children with severe bronchial asthma (BA) Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013